These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5953457)

  • 1. Amino-glutethimide and metastatic adrenal cancer. Maintained reversal (six months) of Cushing's syndrome.
    Schteingart DE; Cash R; Conn JW
    JAMA; 1966 Nov; 198(9):1007-10. PubMed ID: 5953457
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cushing's syndrome].
    Geyer G
    Ann N Y Acad Sci; 1973 Jun; 214():614-9. PubMed ID: 4593436
    [No Abstract]   [Full Text] [Related]  

  • 3. Remission in Cushing's syndrome with o,p'-DDD.
    Southren AL; Tochimoto S; Strom L; Ratuschni A; Ross H; Gordon G
    J Clin Endocrinol Metab; 1966 Mar; 26(3):268-78. PubMed ID: 4286017
    [No Abstract]   [Full Text] [Related]  

  • 4. Results of treatment in 108 patients with Cushing's syndrome.
    Orth DN; Liddle GW
    N Engl J Med; 1971 Jul; 285(5):243-7. PubMed ID: 4326256
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cushing's syndrome. Medical treatment of adrenal hypercorticism].
    Bricaire H; Luton JP
    Horm Res; 1980; 13(4-5):317-24. PubMed ID: 7274999
    [No Abstract]   [Full Text] [Related]  

  • 6. Aminoglutethimide and metyrapone in the management of Cushing's syndrome.
    Thorén M; Adamson U; Sjöberg HE
    Acta Endocrinol (Copenh); 1985 Aug; 109(4):451-7. PubMed ID: 3898689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinico-hormonological study of the effects of aminoglutethimide in a case of adrenal cortex carcinoma].
    Rolandi E; Bianchi G
    Arch Maragliano Patol Clin; 1971; 27(5):223-32. PubMed ID: 5172809
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of aminoglutethimide and reserpine on the human pituitary-adrenal axis: remission of a case of Cushing's disease.
    Givens JR; Camacho A; Patterson P
    Metabolism; 1970 Oct; 19(10):818-30. PubMed ID: 4918596
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of O,p'DDD and aminoglutethimide on metastatic adrenocortical carcinoma.
    Bochner F; Lloyd HM; Roeser HP; Thomas MJ
    Med J Aust; 1969 Apr; 1(16):809-12. PubMed ID: 5769733
    [No Abstract]   [Full Text] [Related]  

  • 10. Aminoglutethimide in the treatment of Cushing's syndrome.
    Misbin RI; Canary J; Willard D
    J Clin Pharmacol; 1976; 16(11-12):645-51. PubMed ID: 993360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical experiences with aminoglutethimide (Elipten), a new inhibitor of steroid biosynthesis in the adrenal gland].
    Horký K; Küchel O; Gregorová I; Jiránková J; Matys Z
    Schweiz Med Wochenschr; 1968 Nov; 98(47):1843-51. PubMed ID: 4236505
    [No Abstract]   [Full Text] [Related]  

  • 12. Medical treatment of Cushing's syndrome with aminoglutethimide and ketoconazole.
    Kong HL; Lee KO; Cheah JS
    Singapore Med J; 1992 Oct; 33(5):523-4. PubMed ID: 1455284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of o,p'-DDD on cortisol secretory pattern in Cushing's syndrome.
    Hellman L; Weitzman ED; Roffwarg H; Fukushima DK; Yoshida K; Zumoff B; Gallagher TF
    J Clin Endocrinol Metab; 1970 Aug; 31(2):227-30. PubMed ID: 4316529
    [No Abstract]   [Full Text] [Related]  

  • 14. [A case of Cushing's disease treated by aminoglutethimide].
    Thevenet M; Lumbroso P; Netter A
    Ann Endocrinol (Paris); 1968; 29(3):346-50. PubMed ID: 4326387
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical and biological study of an inhibitor of adrenocortical hormone synthesis: aminoglutethinide].
    Philbert M; Laudat MH; Laudat P; Bricaire H
    Ann Endocrinol (Paris); 1968; 29(2):189-210. PubMed ID: 4298418
    [No Abstract]   [Full Text] [Related]  

  • 16. [Present knowledge on the treatment of Cushing's syndrome].
    Bricaire H; Albeaux-Fernet M; Lumbroso P; Netter A; Sebaoun J
    Presse Med (1893); 1969 Nov; 77(46):1665-8. PubMed ID: 5380390
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of chlodithane (o,p'-DDD) on transcortin binding ability in Itsenko-Cushing's disease].
    Tron'ko MD
    Fiziol Zh; 1970; 16(6):844-5. PubMed ID: 5520073
    [No Abstract]   [Full Text] [Related]  

  • 18. [Trial treatment of Cushing's syndrome with OP'DDD in children].
    Canlorbe P; Vassal J; Job JC
    Ann Pediatr (Paris); 1971 Oct; 18(10):609-16. PubMed ID: 5126454
    [No Abstract]   [Full Text] [Related]  

  • 19. [Various etiologies and therapeutic possibilities in Cushing's syndrome. 2].
    Staub JJ; Luton JP; Philbert M; Bricaire H
    Praxis; 1968 Oct; 57(43):1493-8. PubMed ID: 5756517
    [No Abstract]   [Full Text] [Related]  

  • 20. Values for urinary free cortisol during treatment with amino-glutethimide for Cushing's syndrome.
    Schmitt KW; Juselius R; Hanlon J; Steed D
    Clin Chem; 1973 Sep; 19(9):1067-8. PubMed ID: 4744809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.